BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Maintains Target Price $25
Morgan Stanley Maintains Afya Ltd(AFYA.US) With Hold Rating, Raises Target Price to $19
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Maintains Target Price $25
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Announces Target Price $25
Morgan Stanley Maintains Afya Ltd(AFYA.US) With Hold Rating, Maintains Target Price $18
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating
Afya Price Target Announced at $19.50/Share by UBS
Afya Initiated at Neutral by UBS
Afya Analyst Ratings
UBS Initiates Coverage On Afya With Neutral Rating, Announces Price Target of $19.5
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Maintains Target Price $25
Morgan Stanley Maintains Afya Ltd(AFYA.US) With Hold Rating, Cuts Target Price to $18
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Raises Target Price to $25
Afya Analyst Ratings
Morgan Stanley Adjusts Price Target on Afya to $19 From $21, Maintains Equalweight Rating
Afya Analyst Ratings
Afya Analyst Ratings
Morgan Stanley Upgrades Afya to Overweight, Raises Price Target to $20.5
Afya Analyst Ratings
Credit Suisse Adjusts Afya's Price Target to $18 From $19, Keeps Outperform Rating